CE Credit Hours: 1.00 CPEUs
Commission on Dietetic Registration (CDR) - Provider #21328, Activity #151067 approved for 1 CPEU.
CPEU Course Description
There is accumulating evidence that milk shapes the postnatal metabolic environment of the newborn infant. Based on translational research, this CPEU course provides a novel mechanistic link between milk intake and milk miRNA-regulated gene expression of the transcription factor p53 and DNA methyltransferase 1 (DNMT1), two guardians of the human genome, that control transcriptional activity, cell survival, and apoptosis.
Brooke H. Dekofsky, MPH, RD, CLE, CDE was involved in the creation of this course.
Article Author: Melnik, B.C., MD
Exam writer: Tiev LaGuire, M.S.
CPEU Course Objectives
1. Conclude how milk consumption during anti-androgen therapy of prostate cancer could interfere with treatment.
2. Describe how the most abundant miRNA detected in human and cow’s milk plays a role in DNA methylation and gene silencing.
3. Explain the role that the miRNAs found in human and bovine milk have on the gene expression of p53.
4. Identify which milk-treatment process has an inverse association of type 2 diabetes mellitus when these milk products are consumed.
5. Summarize how milk plays a role in interleukin-6 levels.
CPE Level: III
Learning Codes: 2000, 4160, 4170, 5150
Performance Indicators (RDN): 6.2.5, 8.1, 8.1.3 , 8.1.5
Performance Indicators (NTDR): 6.2.5, 8.1, 8.1.3 , 8.3.7
Did you know you can now get UNLIMITED CPEUs for only $75/year?
Click Here to learn more.
Course Date: 2019-04-19
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact firstname.lastname@example.org.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.